Related Experiment Video
Updated: Feb 23, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
The Pertussis resurgence: putting together the pieces of the puzzle
Rotem Lapidot1, Christopher J Gill2,3
1Department of Pediatric Infectious Diseases, Boston Medical Center, Boston, MA USA.
Insights
Rising pertussis cases are linked to acellular pertussis (aP) vaccines. Differences in immune responses compared to whole-cell pertussis (wP) vaccines, particularly the lack of mucosal immunity, may explain the resurgence.
Area of Science:
- Immunology
- Epidemiology
- Vaccinology
Background:
- Pertussis (whooping cough) incidence is increasing globally.
- This rise occurs despite widespread use of acellular pertussis (aP) vaccines.
- Existing explanations like waning immunity and improved diagnostics are insufficient.
Purpose of the Study:
- To investigate the reasons behind the resurgence of pertussis.
- To explore the role of differing immune responses between aP and whole-cell pertussis (wP) vaccines.
- To determine if aP vaccines' lack of mucosal immunity contributes to pertussis incidence.
Main Methods:
- Comparative analysis of immune responses induced by aP versus wP vaccines.
- Review of epidemiological data on pertussis incidence trends.
- Assessment of vaccine-induced immunity, including mucosal immunity.
Main Results:
- Immune responses to aP vaccines differ fundamentally from those induced by wP vaccines.
- aP vaccines do not appear to induce significant mucosal immunity.
- These differences may be a critical factor in the observed pertussis resurgence.
Conclusions:
- The shift from wP to aP vaccines may be a key driver of the current pertussis epidemic.
- Lack of mucosal immunity following aP vaccination warrants further investigation.
- Understanding these vaccine-induced immune differences is crucial for controlling pertussis.
Abstract:
Pertussis incidence is rising in almost every country where acellular pertussis (aP) vaccines have been introduced, and is occurring across all age groups from infancy to adulthood. The key question is why? While several known factors such as waning of immunity, detection bias due to more sensitive tests and higher awareness of the disease among practitioners, and evolutionary shifts among B. pertussis all likely contribute, collectively, these do not adequately explain the existing epidemiologic data, suggesting that additional factors also contribute. Key amongst these is recent data indicating that the immune responses induced by aP vaccines differ fundamentally from those induced by the whole cell pertussis (wP) vaccines, and do not lead to mucosal immunity. If so, it appears likely that differences in how the two categories of vaccines work, may be pivotal to our overall understanding of the pertussis resurgence.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
04:47Author Spotlight: Controlled Human Exposure Model for Tick Research and Lyme Disease Studies
Published on: December 1, 2023
Related Concept Videos
Steps in Outbreak Investigation
Vaccinations
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pneumonia III: Complications and Assessment
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...